Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iterum Therapeutics (ITRM) Return on Equity (2018 - 2022)

Historic Return on Equity for Iterum Therapeutics (ITRM) over the last 5 years, with Q3 2022 value amounting to 1.14%.

  • Iterum Therapeutics' Return on Equity rose 8500.0% to 1.14% in Q3 2022 from the same period last year, while for Sep 2022 it was 1.14%, marking a year-over-year increase of 8500.0%. This contributed to the annual value of 563.47% for FY2021, which is 5621000.0% up from last year.
  • Per Iterum Therapeutics' latest filing, its Return on Equity stood at 1.14% for Q3 2022, which was up 8500.0% from 0.23% recorded in Q2 2022.
  • Over the past 5 years, Iterum Therapeutics' Return on Equity peaked at 14.23% during Q1 2021, and registered a low of 9.66% during Q3 2019.
  • Over the past 5 years, Iterum Therapeutics' median Return on Equity value was 0.58% (recorded in 2018), while the average stood at 0.31%.
  • As far as peak fluctuations go, Iterum Therapeutics' Return on Equity soared by 113200bps in 2021, and later crashed by -141600bps in 2022.
  • Iterum Therapeutics' Return on Equity (Quarter) stood at 0.93% in 2018, then soared by 860bps to 7.06% in 2019, then plummeted by -86bps to 0.99% in 2020, then tumbled by -280bps to 1.78% in 2021, then soared by 36bps to 1.14% in 2022.
  • Its Return on Equity stands at 1.14% for Q3 2022, versus 0.23% for Q2 2022 and 0.08% for Q1 2022.